New heteroaromatic aminations on 5-aryl-1,2,4-triazines and 1,2,4,5-tetrazines by palladium catalysis

Tetrahedron

Volumn 66, Issue 24, 2010, Pages 4383-4389

  Pellegatti, Laurent ^a   Vedrenne, Emeline ^a   Leger, Jean Michel ^b   Jarry, Christian ^b   Routier, Sylvain ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b Laboratoire de Pharmacochimie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZINE DERIVATIVE; AMINE; HETEROCYCLIC COMPOUND; METHYLSULFUR ACID; PALLADIUM; SULFUR ACID DERIVATIVE; TETRAZINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; BUCHWALD HARTWIG REACTION; CATALYSIS; CATALYST; CHEMICAL MODIFICATION; CROSS COUPLING REACTION; PRIORITY JOURNAL; SYNTHESIS;

EID: 77953122472     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.03.099     Document Type: Article

References (33)

1. Lamberth C. Heterocycles 68 (2006) 561
2. Bernstein T.B., and Feinberg S.M. J. Allergy 19 (1948) 393
3. Sayle K.L., Bentley J., Boyle F.T., Calvert A.H., Cheng Y., Curtin N.J., Endicott J.A., Golding B.T., Hardcastle I.R., Jewsbury P., Mesguiche V., Newell D.R., Noble M.E.M., Parsons R.J., Pratt D.J., Wang L.Z., and Griffin R.J. Bioorg. Med. Chem. Lett. 13 (2003) 3079
4. Wang S., Wood G., Meades C., Griffiths G., Midgley C., McNae I., McInnes C., Anderson S., Jackson W., Mezna M., Yuill R., Walkinshaw M., and Fisher P.M. Bioorg. Med. Chem. Lett. 14 (2004) 4237
5. Wang S., Meades C., Wood G., Osnowski A., Anderson S., Yuill R., Thomas M., Mezna M., Jackson M., Midley C., Griffiths M., Fleming I., Green S., McNae I., Wu S.-Y., McInnes C., Zheleva D., Walkinshaw M.D., and Fisher P.M. J. Med. Chem. 47 (2004) 1662
6. Chu X.-J., De Pinto W., Bartkovitz D., So S.-S., Vu B.T., Packman K., Lukacs C., Ding Q., Jiang N., Wang K., Goelzer P., Yin X., Smit M.A., Higgins B.X., Chen Y., Xiang Q., Moliterni J., Kaplan G., Graves B., Lovey A., and Fotouhi N. J. Med. Chem. 49 (2006) 6549
7. Dounay A.B., Barta N.S., Bikker J.A., Borosky S.A., Campbell B.M., Crawford C., Denny L., Evans L.M., Gray D.L., Lee P., Lenoir E.A., and Xu W. Bioorg. Med. Chem. Lett. 19 (2009) 1159
8. For examples of activities of functionalized 3-amino-1,2,4-triazines, see:
9. Bondinell, W.E.; Holt, D.A.; Lago, M.A.; Neeb, M.J. Semones, M.A. Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases. WO 076984, 2002;
10. Cao, J.; Green, J.; Moon, Y.C.; Wang, J.; Ledeboer, M.; Gao, H. Harrington, E. Inhibitors of C-JUN N-Terminal kinases (JNK) and others protein kinases. WO 083667, 2002;
11. Lewi, P.J.; De Jonge, M.R.; Koymans, L.M.H.; Vinkers, H.M.; Dayeaert, F.F.D.; Heeres, J.; Leenders, R.G.G.; Hoornaert, G.J.C.; Kilonda, A.; Ludovici, D.W. HIV inhibiting 1,2,4-triazines. WO 074266, 2004;
12. Hoornaert, G.J.C.; Kilonda, A.; Heeres, J.; Lewi, P.J.; De Jonge, M.R.; Dayeaert, F.F.D.; Vinkers, H.M.; Koymans, L.M.H. HIV inhibiting 1,2,4-triazin-6-one derivatives. WO 015985, 2006;
13. Boyle, R.G.; Travers, S. Pharmaceuticals Compounds. WO 059259, 2008.
14. Pellegatti L., Vedrenne E., Leger J.-M., Jarry C., and Routier S. Synlett (2009) 2137
15. For other Pd-catalyzed C-3 functionalizations, see:
16. Alphonse F.-A., Suzenet F., Keromnes A., Lebret B., and Guillaumet G. Org. Lett. 5 (2003) 803
17. Alphonse F.-A., Suzenet F., Keromnes A., Lebret B., and Guillaumet G. Synthesis 17 (2004) 2893
18. Garnier E., Audoux J., Pasquinet E., Suzenet F., Poullain D., Lebret B., and Guillaumet G. J. Org. Chem. 69 (2004) 7809
19. For others desulfuratives cross-coupling reactions reported by our group, see:
20. Silva S., Tardy S., Routier S., Suzenet F., Tatibouët A., Rauter A.P., and Rollin P. Tetrahedron Lett. 49 (2008) 5583
21. Silva S., Sylla B., Suzenet F., Tatibouët A., Rauter A.P., and Rollin P. Org. Lett. 10 (2008) 853
22. Liebeskind L.S., and Srogl J. J. Am. Chem. Soc. 122 (2000) 11260
23. Savarin C., and Liebeskind L.S. Org. Lett. 3 (2001) 91
24. Savarin C., Srogl J., and Liebeskind L.S. Org. Lett. 3 (2001) 2149
25. Egi M., and Liebeskind L.S. Org. Lett. 5 (2003) 801
26. Prokopcová H., and Kappe O. Angew. Chem., Int. Ed. 47 (2008) 2
27. Heilman W.P., Heilman R.D., Scozzie J.A., Wayner R.J., Gullo J.M., and Ariyan Z.S. J. Med. Chem. 22 (1979) 671
28. Joshi K.C., Dubey K., and Dandia A. Heterocycles 16 (1981) 671
29. More than 20 h were needed to get full completion when the reaction was run under reflux conditions. See Ref. 5.
30. CCDC 755055 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at www.ccdc.cam.uk/cont/retrieving.html (or from Cambridge Crystallographic Data Centre, University Chemical Lab, 12, Union Road, Cambridge, CB2 1EZ, U.K.; E-mail: deposit@ccdc.cam.ac.uk).
31. Fields and Boger described that N-substituted 6-(methylthio)-1,2,4,5-tetrazin-3-amines could be obtained through the direct displacement of the SMe moiety by amines, without the use of palladium catalysis. However the reported yields were poor. See:
32. Fields S.C., Parker M., and Erickson W.R. J. Org. Chem. 59 (1994) 8284
33. 2/CuMeSal, in the 1,2,4-triazine and 1,2,4,5-tetrazine series failed in our hands